Announced
Completed
Synopsis
Cleveland Avenue, a venture capital investment company, led a $45m Series B funding round in Nuritas, a biotechnology company, with participation from Wheatsheaf Group, the European Circular Bioeconomy Fund, Vertex, Nutresa Ventures, CJ. Cultivian Sandbox Ventures and VisVires New Protein. “We are pleased to join Nuritas as it prepares to launch new consumer products alongside an impressive pipeline of novel molecules and ongoing partnerships with global consumer product businesses. Nuritas’ capabilities match Wheatsheaf’s mission to re-shape how food is produced and consumed while benefiting the environment and human health,” Stephan Dolezalek, Wheatsheaf Group Executive Director.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.